Method for treatment of allergic disorders and immune complex diseases
US4540569A · kind A · utility
6Cited by
0References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 1982 |
| Grant date | Sep 10, 1985 |
| Priority date | — |
| Expiry date | Apr 5, 2002 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/49
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Therapeutic agent for the treatment of allergic disorders, immune complex diseases and tumors, which contains a human urinary acid protease as an active ingredient, and a method for treating allergic disorders, immune complex diseases and tumors by administering the said acid protease, which has never been used as a therapeutic agent for allergic disorders, immune complex diseases and tumors. Since the acid protease is a protein of human origin, the probability of adverse reactions such as anaphylactic shock due to the antigenicity of the acid protease is believed to be extremely small.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.